5-Ethyl-1H-pyrazole-3-carboxylic acid, 95.0%, 50mg

2,6-Dichloro-4-methylnicotinamide, 95.0%, 1g

2,6,6-Trimethylcyclohexa-1,3-dienecarbaldehyde, 90.0%, 1g

NOTOGINSENOSIDE R1, 98%, 250mg

(4-Fluoro-3-nitrophenyl)methanamine hydrochloride, 95.0%, 1g

Ethyl (3R,4R,5S)-4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate hydrochloride, 98%, 1g

3,6-Dibromo-o-xylene, 95.0%, 10g

(R)-Methyl 4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate, 98%, 1g

(R)-3-Amino-3-(4-methoxyphenyl)propan-1-ol, 97%, 1g

(R)-2-Cyclopropyl-piperazine dihydrochloride, 98%, 500mg

2-Methyl-3-(trifluoromethyl)benzonitrile, 95.0%, 25g

6-Chloro-2-oxindole, 97.0%, 100g

Ethyl 2-(1H-1,2,3-benzotriazol-1-yl)-2-(phenylformamido)acetate, 1g